nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies
|
Ranieri, G. |
|
2013 |
88 |
1 |
p. 187-197 11 p. |
artikel |
2 |
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysis
|
Theurich, Sebastian |
|
2013 |
88 |
1 |
p. 178-186 9 p. |
artikel |
3 |
Biomolecular markers of cancer-associated thromboembolism
|
Hanna, Diana L. |
|
2013 |
88 |
1 |
p. 19-29 11 p. |
artikel |
4 |
Cancer in developing countries: The next most preventable pandemic. The global problem of cancer
|
López-Gómez, Miriam |
|
2013 |
88 |
1 |
p. 117-122 6 p. |
artikel |
5 |
CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
|
Veillette, André |
|
2013 |
88 |
1 |
p. 168-177 10 p. |
artikel |
6 |
Current status and future directions in induction chemotherapy for head and neck cancer
|
Argiris, Athanassios |
|
2013 |
88 |
1 |
p. 57-74 18 p. |
artikel |
7 |
Design of oncology clinical trials: A review
|
Ananthakrishnan, Revathi |
|
2013 |
88 |
1 |
p. 144-153 10 p. |
artikel |
8 |
Editorial Board
|
|
|
2013 |
88 |
1 |
p. CO2- 1 p. |
artikel |
9 |
Energy management – a critical role in cancer induction?
|
Garland, J. |
|
2013 |
88 |
1 |
p. 198-217 20 p. |
artikel |
10 |
Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: A review of pharmacologic and clinical differences and applications in patients with cancer
|
Walenga, Jeanine M. |
|
2013 |
88 |
1 |
p. 1-18 18 p. |
artikel |
11 |
HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: A review
|
Thibault, Constance |
|
2013 |
88 |
1 |
p. 123-133 11 p. |
artikel |
12 |
Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia
|
Koppelmans, Vincent |
|
2013 |
88 |
1 |
p. 87-101 15 p. |
artikel |
13 |
Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis
|
Diaz-Padilla, Ivan |
|
2013 |
88 |
1 |
p. 154-167 14 p. |
artikel |
14 |
mTOR inhibitors in advanced renal cell carcinomas: From biology to clinical practice
|
Barthélémy, Philippe |
|
2013 |
88 |
1 |
p. 42-56 15 p. |
artikel |
15 |
Risk of hematologic toxicities in patients with solid tumors treated with everolimus: A systematic review and meta-analysis
|
Funakoshi, Tomohiro |
|
2013 |
88 |
1 |
p. 30-41 12 p. |
artikel |
16 |
State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review
|
Berardi, Rossana |
|
2013 |
88 |
1 |
p. 75-86 12 p. |
artikel |
17 |
Supportive care needs of hematological cancer survivors: A critical review of the literature
|
Hall, Alix |
|
2013 |
88 |
1 |
p. 102-116 15 p. |
artikel |
18 |
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
|
Guthrie, Graeme J.K. |
|
2013 |
88 |
1 |
p. 218-230 13 p. |
artikel |
19 |
Tu-be or not tu-be: That is the question… About serous ovarian carcinogenesis
|
Chene, G. |
|
2013 |
88 |
1 |
p. 134-143 10 p. |
artikel |